# Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine

> **NCT00164411** · PHASE1 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 30 (—)

## Conditions studied

- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** Tetanus-diphtheria toxoids (Td)
- **BIOLOGICAL:** 7-valent pneumococcal conjugate vaccine
- **BIOLOGICAL:** 23-valent polysaccharide vaccine

## Key facts

- **NCT ID:** NCT00164411
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 30 (—)
- **Last updated:** 2012-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164411, "Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00164411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*